FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts6366
Avg. Estimate-0.29-0.29-1.6-1.11
Low Estimate-0.39-0.35-1.77-1.65
High Estimate-0.23-0.22-1.2-0.7
Year Ago EPS-0.42-0.39-1.49-1.6
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts6266
Avg. Estimate14.25M16.54M36.25M87.98M
Low Estimate13M16.09M35.2M80M
High Estimate16M17M37.5M95.76M
Year Ago Sales2.83M4.17M4.96M36.25M
Sales Growth (year/est)403.40%296.70%631.10%142.70%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.33-0.36-0.36-0.31
EPS Actual-0.42-0.39-0.34-0.69
Difference-0.09-0.030.02-0.38
Surprise %-27.30%-8.30%5.60%-122.60%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.29-0.29-1.6-1.11
7 Days Ago-0.29-0.29-1.6-1.09
30 Days Ago-0.29-0.31-1.64-1.13
60 Days Ago-0.29-0.31-1.64-1.05
90 Days Ago-0.29-0.26-1.32-1.02
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/A111
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesFOLDIndustrySectorS&P 500
Current Qtr.31.00%N/AN/A0.26
Next Qtr.25.60%N/AN/A0.33
Current Year-7.40%N/AN/A0.09
Next Year30.60%N/AN/A0.15
Next 5 Years (per annum)60.80%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A